PREPOPIK (citric acid; magnesium oxide; sodium picosulfate) by Ferring Pharmaceuticals is metabolite: bis-(p-hydroxy-phenyl)-pyridyl-2-methane, bhpm, which acts directly on the colonic mucosa to stimulate colonic peristalsis. First approved in 2012.
Drug data last refreshed 18h ago · AI intelligence enriched 2w ago
PREPOPIK is an oral bowel preparation solution combining sodium picosulfate (a stimulant laxative), magnesium oxide, and citric acid to cleanse the colon prior to colonoscopy. The sodium picosulfate metabolite BHPM stimulates colonic peristalsis while the in situ magnesium citrate acts as an osmotic agent to retain water in the GI tract. It is indicated for adult patients requiring bowel cleansing before colonoscopy.
Product faces imminent loss of exclusivity in 2.5 years with moderate competitive pressure (15 competitors); brand team will shift from growth maintenance to defensive positioning and generic transition planning.
metabolite: bis-(p-hydroxy-phenyl)-pyridyl-2-methane, BHPM, which acts directly on the colonic mucosa to stimulate colonic peristalsis. Magnesium oxide and citric acid react to create magnesium citrate in solution, which is an osmotic agent that causes water to be retained within the…
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
A Study Comparing the Sodium Picosulfate, Magnesium Oxide and Anhydrous Citric Acid Oral Solution With PREPOPIK® for Colon Cleansing in Preparation for Colonoscopy
Efficacy and Safety of Prepopik® in Children for Overall Colon Cleansing in Preparation for Colonoscopy
Worked on PREPOPIK at Ferring Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
LOE in ~3 years — strategic planning for patent cliff underway
Working on PREPOPIK offers exposure to mature product management and defensive commercial strategy in a competitive, commoditized market. Career growth may be limited by the LOE trajectory; roles emphasize cost management, market share defense, and transition planning rather than innovation or expansion.
Upgrade to Pro to access patent cliff timelines and LOE dates and other premium pharma intelligence.
Upgrade to Pro — $25/mo